Skip to main content
Clinical Trials/NCT05275153
NCT05275153
Completed
Not Applicable

Effectiveness of a Home-Based Cognitive Rehabilitation Program Driven by a Tablet Application in Patients With Mild Cognitive Impairment

Pusan National University Yangsan Hospital1 site in 1 country50 target enrollmentApril 22, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cognitive Impairment
Sponsor
Pusan National University Yangsan Hospital
Enrollment
50
Locations
1
Primary Endpoint
Change of the Korean-Montreal cognitive assessment(MoCA) score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In this study, a more specific and systematic Home-Based Cognitive Rehabilitation Program Driven by a Tablet Application is developed and the purpose of the program is to check whether cognitive function is improved when the program is applied to patients with MCI.

Detailed Description

The subjects of recruitment were the elderly with mild cognitive impairment living in the local community. Assessments were conducted 7 days before and after the intervention. Subjects received Korean-Montreal Cognitive Assessment(MoCA), semantic verbal emory test (SVLT), number memorization test; Digit Span Test (DST), category word fluency test (CWFT), phonemic word fluency test (PWFT), Korean-mini mental state test (K-MMSE), and geriatric depression scale (GDS) before and 8 weeks after the intervention.

Registry
clinicaltrials.gov
Start Date
April 22, 2020
End Date
August 2, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yong-il Shin

Professor

Pusan National University Yangsan Hospital

Eligibility Criteria

Inclusion Criteria

  • Men and women over the age of 55
  • Those who have visual and auditory abilities without difficulties in conducting this research
  • Those with K-MMSE (Korean-Mini Mental State Examination) score of 24 or higher and 16≤K-MoCA score\<23
  • In the case of patients taking dementia treatment, those who have the same treatment regimen and dose for 3 months or more from the screening date
  • A person who can understand and respond to the questionnaire questions.
  • A person who voluntarily decided to participate in this study and gave written consent to the informed consent form

Exclusion Criteria

  • Those with a history of alcohol or drug abuse,
  • Those with a past history of uniaxial psychiatric disorders, including intellectual disability, schizophrenia, alcoholism, and bipolar disorder
  • A person who is unable to communicate
  • Those who show all neurological symptoms that cause cognitive decline, such as Parkinson's disease, cerebral hemorrhage, brain tumor, and hydrocephalus
  • Those with a record of being unconscious for more than 1 hour due to head trauma or mild repetitive head trauma
  • Those with symptoms of depression that may affect cognitive function

Outcomes

Primary Outcomes

Change of the Korean-Montreal cognitive assessment(MoCA) score

Time Frame: Baseline and Week 8

It is a tool to evaluate overall cognitive function. Possible scores range from 0(lowest cognitive function) to 30 (highest cognitive function). Change = Paired t-test with baseline score and week 8 score.

Secondary Outcomes

  • Change of the semantic verbal emory test (SVLT) score(Baseline and Week 8)
  • Change of the phonemic word fluency test (PWFT) score(Baseline and Week 8)
  • Change of the category word fluency test (CWFT) score(Baseline and Week 8)
  • Change of the Digit Span Test (DST) score(Baseline and Week 8)
  • Change of the geriatric depression scale (GDS) score(Baseline and Week 8)

Study Sites (1)

Loading locations...

Similar Trials